| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2134 | flu-dnb | Novel photolabile NO donor |
|
| DCC2135 | Flufenacet | Herbicide, inhibiting very-long-chain fatty acid elongase (VLCFAE) synthesis |
|
| DCC2136 | Fluo-3 | Green-fluorescent intracellular calcium indicator |
|
| DCC2137 | Fluo-3 Am | Green-fluorescent intracellular calcium indicator |
|
| DCC2138 | Fluoroclorgyline | Monoamine oxidase A (MAO-A) specific inhibitor |
|
| DCC2139 | Fluoroethylnormemantine | Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor |
|
| DCC2140 | Fluoroethylnormemantine Hcl | Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor |
|
| DCC2141 | fluoxatrobin | Fungicide for the control of fungal diseases such as early blight, late blight, leaf spots, leaf rust, and Rhizoctonia solani. |
|
| DCC2142 | Fluperlapine | Atypical antipsychotic agent and ligand for the serotonin receptors 5-HT6/5-HT7 |
|
| DCC2143 | Fluphenazine Decanoate | Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia |
|
| DCC2144 | Fluphenazine Decanoate Dihydrochloride | Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia |
|
| DCC2145 | Flutazolam | Benzodiazepine with sedative, muscle relaxant, anticonvulsant, and anxiolytic activities |
|
| DCC2146 | Flutonidine | alpha2-Adrenergic receptor agonist |
|
| DCC2147 | Fm4-64 | Fluorescent probe for monitoring synaptic activity at neuromuscular junctions |
|
| DCC2148 | Fm-476 | Negative control for FM-381 |
|
| DCC2149 | Fm-743 | Negative control for Skepinone-L |
|
| DCC2150 | Fmf-01-086-2 | Novel highly selective inhibitor of Aurora kinases A, B and C, with potent cellular activity and minimal off-target activity (PLK4) |
|
| DCC2151 | Fmf-02-063-1 | Novel potent and selective Dual inhibitor of PI3K-δ and PI3K-γ |
|
| DCC2152 | Fmf-04-159-r | Novel potent dual CDK14 and CDK16 inhibitor |
|
| DCC2153 | Fmp-401319-3 | Novel concentration-dependent inhibitor of CRF1R-pPL cotranslational translocation at the level of the Sec61 complex |
|
| DCC2154 | Fnd-4b | Novel AMPK activator, inhibiting growth and induces apoptosis in colon cancer and increasing apoptosis in triple negative and estrogen-receptor positive breast cancers |
|
| DCC2155 | Fndr-20081 | First in class anti-tubercular agent against sensitive and drug-resistant Mycobacterium tuberculosis (Mtb) |
|
| DCC2156 | Fnir-tag-co2h | Novel fluorescent near-infrared (NIR) linker for building brighter labeled biomolecules, exhibiting no evidence of H-aggregation even at high labeling density when appended to monoclonal antibodies or virus-like particles |
|
| DCC2157 | Fol7185 | Inhibitor of IspD and IspE enzymes isolated from bacteria |
|
| DCC2158 | Folate-arv-771 | Novel BRD PROTAC, being capable of degrading BRDs in a folate receptor-dependent manner in cancer cells |
|
| DCC2159 | Folate-ms99 | Novel ALK PROTAC, being capable of degrading ALK in a folate receptor-dependent manner in cancer cells |
|
| DCC2160 | Fomocaine | Local anaesthetic agent, blocking voltage-gated Na(+) currents in neurons |
|
| DCC2161 | Formyl Lenalidomide | Impurity of Lenalidomide |
|
| DCC2162 | Fosmidomycin | Natural antibiotic, acting as an inhibitor of DOXP reductoisomerase |
|
| DCC2163 | Fotagliptin | Novel dipeptidyl peptidase IV (DPP4) inhibitor |
|
